Source 1primary paper2025MED
Toolkit/vesicle fluid culture
vesicle fluid culture
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
Both vesicle fluid culture and next-generation sequencing (NGS) of blood samples confirmed the presence of Escherichia coli.
Usefulness & Problems
Why this is useful
Vesicle fluid culture was used to confirm Escherichia coli in the patient's bullous skin lesions. The abstract presents it as one component of combined early microbial testing.; microbial confirmation from bullous skin lesion fluid; early combined microbial testing in immunosuppressed patients with skin infections
Source:
Vesicle fluid culture was used to confirm Escherichia coli in the patient's bullous skin lesions. The abstract presents it as one component of combined early microbial testing.
Source:
microbial confirmation from bullous skin lesion fluid
Source:
early combined microbial testing in immunosuppressed patients with skin infections
Problem solved
It helps identify the pathogen directly from the lesion site in atypical bullous erysipelas. In this case, it contributed to confirmation of the causative organism.; provides lesion-based microbiological confirmation of the causative pathogen
Source:
It helps identify the pathogen directly from the lesion site in atypical bullous erysipelas. In this case, it contributed to confirmation of the causative organism.
Source:
provides lesion-based microbiological confirmation of the causative pathogen
Problem links
provides lesion-based microbiological confirmation of the causative pathogen
LiteratureIt helps identify the pathogen directly from the lesion site in atypical bullous erysipelas. In this case, it contributed to confirmation of the causative organism.
Source:
It helps identify the pathogen directly from the lesion site in atypical bullous erysipelas. In this case, it contributed to confirmation of the causative organism.
Published Workflows
Objective: Diagnose the causative pathogen rapidly in a severe atypical bullous skin infection in an immunosuppressed patient and use that information to guide escalation then de-escalation of anti-infective therapy.
Why it works: The abstract states that early combined microbial culture and NGS can identify the pathogenic microorganism, enabling de-escalation within 24 hours of pathogen identification after initial broad-spectrum coverage.
combined lesion culture and blood-sample NGS for pathogen confirmationbroad-spectrum empiric coverage before identification followed by targeted de-escalation after identificationmicrobial culturenext-generation sequencingtiered anti-infective management
Stages
- 1.Early combined microbial testing(functional_characterization)
The abstract recommends early combined microbial culture and NGS testing so that the causative pathogen can be identified in rapidly progressive infection.
Selection: confirmation of the pathogenic microorganism using vesicle fluid culture and blood-sample NGS
- 2.Initial broad-spectrum anti-infective treatment(decision_gate)
The abstract states that a tiered anti-infective strategy is paramount, beginning with broad-spectrum coverage because severe infection can progress rapidly.
Selection: empiric coverage for both Gram-negative and Gram-positive bacteria in severe infection
- 3.De-escalation after pathogen confirmation(decision_gate)
The abstract recommends de-escalation within 24 hours of pathogen identification as part of the tiered anti-infective strategy.
Selection: pathogen identification confirming Escherichia coli
Steps
- 1.Obtain vesicle fluid culture and blood-sample NGSdiagnostic assays
Confirm the pathogenic microorganism in a rapidly progressive atypical bullous skin infection.
The abstract advises early combined microbial culture and NGS testing because the disease can progress to shock within 24 hours.
- 2.Escalate to broad-spectrum coverage for Gram-negative and Gram-positive bacteria
Provide immediate empiric anti-infective coverage during severe infection before targeted narrowing.
This occurs before pathogen-guided narrowing because the patient had rapidly progressive severe infection and initial cefuroxime treatment was ineffective.
- 3.De-escalate antibiotics within 24 hours of pathogen identification
Narrow therapy after confirmation of the causative microorganism.
The abstract states that de-escalation follows pathogen identification and should occur within 24 hours.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Target processes
No target processes tagged yet.
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
The method requires vesicle fluid from the skin lesions and culture-based microbiology capability. Its use depends on the presence of bullous or vesicular lesions that can be sampled.; requires accessible vesicle fluid from bullous lesions; is recommended in combination with NGS testing
The abstract does not state that vesicle fluid culture alone is sufficient for all cases, and it recommends combining culture with NGS. Its applicability may be limited when vesicle fluid is not available.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Observations
successHuman Clinicaltherapeutic usehuman
Inferred from claim c1 during normalization. In this immunosuppressed patient with atypical bullous erysipelas, vesicle fluid culture and blood-sample NGS both confirmed Escherichia coli. Derived from claim c1.
Source:
Supporting Sources
Ranked Claims
In this immunosuppressed patient with atypical bullous erysipelas, vesicle fluid culture and blood-sample NGS both confirmed Escherichia coli.
For immunosuppressed patients with skin infections, early combined microbial culture and NGS testing with initial broad-spectrum coverage followed by de-escalation within 24 hours of pathogen identification is advisable.
de escalation timing after pathogen identification 24 hours
Approval Evidence
1 source2 linked approval claimsfirst-pass slug vesicle-fluid-culture
Both vesicle fluid culture and next-generation sequencing (NGS) of blood samples confirmed the presence of Escherichia coli.
Source:
case observationsupports
In this immunosuppressed patient with atypical bullous erysipelas, vesicle fluid culture and blood-sample NGS both confirmed Escherichia coli.
Source:
management recommendationsupports
For immunosuppressed patients with skin infections, early combined microbial culture and NGS testing with initial broad-spectrum coverage followed by de-escalation within 24 hours of pathogen identification is advisable.
Source:
Comparisons
Source-stated alternatives
The abstract explicitly pairs vesicle fluid culture with blood-sample NGS. It does not describe either method as clearly superior in this case.
Source:
The abstract explicitly pairs vesicle fluid culture with blood-sample NGS. It does not describe either method as clearly superior in this case.
Source-backed strengths
directly confirmed Escherichia coli in this case
Source:
directly confirmed Escherichia coli in this case
Compared with Langendorff perfused heart electrical recordings
vesicle fluid culture and Langendorff perfused heart electrical recordings address a similar problem space.
Shared frame: same top-level item type
Strengths here: looks easier to implement in practice.
Compared with native green gel system
vesicle fluid culture and native green gel system address a similar problem space.
Shared frame: same top-level item type
Strengths here: looks easier to implement in practice.
vesicle fluid culture and sub-picosecond pump-probe analysis of bacteriorhodopsin pigments address a similar problem space.
Shared frame: same top-level item type
Strengths here: looks easier to implement in practice.
Ranked Citations
- 1.